Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of biologically active compounds targeting central nervous system disorders and psychiatric conditions. Its structure supports the creation of potent small-molecule drugs due to the conformational constraint and enhanced metabolic stability provided by the fluorinated pyrrolidine ring. Commonly employed in medicinal chemistry for optimizing drug candidates requiring improved bioavailability and target selectivity. Also utilized in the preparation of enzyme inhibitors and receptor modulators, especially in research focused on neurodegenerative diseases and mood disorders.